Net profit of Concord Biotech declined 33.59% to Rs 63.58 crore in the quarter ended September 2025 as against Rs 95.74 crore during the previous quarter ended September 2024. Sales declined 20.35% to Rs 247.06 crore in the quarter ended September 2025 as against Rs 310.18 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 247.06 | 310.18 | -20 |
| OPM % | 35.82 | 43.11 | - |
| PBDT | 104.08 | 143.65 | -28 |
| PBT | 85.68 | 130.34 | -34 |
| NP | 63.58 | 95.74 | -34 |